Article Sidebar

Submitted
26 July 2017
Accepted
26 July 2017
Published
8 August 2017
Download
PDF
Statistic
Read Counter : 6935 Download : 5695

Main Article Content

Abstract

Pneumonia is an infectious disease that causes acute inflammation of the lung parenchyma and compaction exudate in the lung tissue. In addition to causing significant morbidity and mortality, pneumonia is also difficult to diagnose, treatments are less precise and less taken seriously. Pneumonia caused the death of 14% of children under five in Indonesia, with a mortality rate of 83 children per day. The difficulty of diagnosis, the selection of a less appropriate antibiotics, side effects, differences in pharmacokinetics and pharmacodynamics of the drug in infants and antibiotics resistance is to be a problem in itself. Therefore it is necessary to study the analysis of the use of antibiotics in patients with pneumonia of children aged 3 months till 5 years. The aim of this research to analyze antibiotics therapy in patients with pneumonia of children aged 3 months till 5 years. Method: an observational cohort analysis was carried out in the Pediatrics Respirology Division Dr. Soetomo Hospital Surabaya. Data was collected from February to May 2014. Patients who met the inclusion criteria were observed prospectively and the quantity and quality of antibiotics usage assessed with Gyssens category. Result: from February to May 2014 period, prospectively, the antibiotics usage quantitative evaluation used DDD/patient days shows that ampicillin 34.39DDD/100 patient days. Qualitative evaluation using Gyssens category on 75 antibiotics therapy shows that 32% considered appropriate. So, this study showed that ampicillin is most widely and qualitative analysis, only 32% of rational use of antibiotics.

Keywords

pneumonia pediatric antibiotics gyssens category DDD/100 patient days

Article Details

License

  • Folia Medica Indonesiana is a scientific peer-reviewed article which freely available to be accessed, downloaded, and used for research purposes. Folia Medica Indonesiana (p-ISSN: 2541-1012; e-ISSN: 2528-2018) is licensed under a Creative Commons Attribution 4.0 International License. Manuscripts submitted to Folia Medica Indonesiana are published under the terms of the Creative Commons License. The terms of the license are:

    Attribution ” You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

    NonCommercial ” You may not use the material for commercial purposes.

    ShareAlike ” If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.

    No additional restrictions ” You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

    You  are free to :

    Share ” copy and redistribute the material in any medium or format.

    Adapt ” remix, transform, and build upon the material.

How to Cite
Aryani, D. E., Hasmono, D., Zairina, N., & Setiawan, L. (2017). ANALYSIS OF ANTIBIOTICS USE IN PEDIATRIC PNEUMONIA PATIENTS AGED 3 MONTHS - 5 YEARS. Folia Medica Indonesiana, 52(2), 108–115. https://doi.org/10.20473/fmi.v52i2.5224
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX

References

  1. American Heart Association (2015). Highlights of the 2015 AHA guidelines update for CPR and ECC. Available from http://eccguidelines.heart.org/wp-content/uploads/2015/10/2015-AHA-Guidelines-Highlights-English.pdf. Accessed October 14, 2014
  2. Asih R, Aini Z, Setiawati L (2011). Risk factor of bacteremia in children with pneumonia. Indonesian Journal of Tropical and Infectious Disease 2, 34-37
  3. Bradley JS, Byington CL, Shah SS, Alverson B, Carter ER, Harrison C, Kaplan SL, Mace SE, McCracken Jr GH, Moore MR, St Peter SD, Stockwell JA, Swason JT (2011). The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the pediatric infectious diseases society of America. Clinical Infectious Diseases Advance (IDSA Guidelines)
  4. Cincinnati Children Hospital Medical Center (2005). Community Acquired Pneumonia in Children 60 days through 17 years of age - Evidence-Based Care Guideline for Children with Community Acquired Pneumonia
  5. Clinical Practice Guidelines (2009). Clinical Practice Guidelines, Department of Pulmonology, Dr Soetomo Hospital, Surabaya
  6. Clinical Practice Guidelines (2013). Clinical Practice Guidelines, Department of Pulmonology, Dr Soetomo Hospital, Surabaya
  7. Cunha BA (2009). Severe community-acquired pneumonia in critical care. In: Cunha BA (ed). Infectious Diseases in Critical Care Medicine, 3th ed, Florida, CRC Press, p 164-175
  8. Finkel R, Clark MA, Cubeddu LX (2009). Principles of antimicrobial therapy. In: Harvey RA and Champe PC (eds). Lippincott's Illustrated Re-views Pharmacology 4th ed, Philadelphia, Lippincott William & Wilkins
  9. Grayson LM, Kucers A, Crowe S, McCarthy J, Mills J, Mouton J, Norrby R, Paterson D, Pfaller M (2010). Kucers' The Use of Antibiotics Sixth Edition: A Clinical Review of Antibacterial, Antifungal, and Antiviral Drugs, Volume 1, Florida, CRC Press
  10. Health Office, Province of East Java (2010). Profil Kesehatan Provinsi Jawa Timur Tahun 2010, Surabaya
  11. Jesenak M, Ciljakova M, Rennerova Z, Babusikova E, Banovcin P (2011). Recurrent respiratory infections in children – definition, diagnostic approach, treatment and prevention. In: MartAn-Loeches I (ed). Bronchitis, Croatia, InTech, p 119-148
  12. Mandell LA and Wunderink R (2010). Pneumonia. In: Kasper DL and Fauci AS (eds). Harrison's Infectious Disease, New York, McGraw-Hill Professional
  13. Nataprawira HM, Alwi EH, Adriani N (2010). Faktor risiko morbiditas dan mortalitas pneumonia berat pada anak usia balita. Majalah Kedokteran Indonesia 60, 443-447
  14. PrabhuDas M, Adkins B, Gans H, King C, Levy O, Ramilo O, Siegrist CA (2011). Challenges in infant immunity: implications for responses to infection and vaccines. Nature Immunology 12, 189-194
  15. Purniti PS, Subanada IB, Kari IK, Arhana BNP, Iswari IS, Tarini NMA (2011). Surveilan pneumokokus dan dampak pneumonia pada anak balita. Sari Pediatri 12, 359-364
  16. Ram G and Chinen (2011). Infection and immuno-deficiency in down syndrome. Clin Exp Immunol 164, 9-16
  17. Said M (2010). Pneumonia. In: Rahajoe NN, Suprayitno B, Setyanto DB (eds). Buku Ajar Respirologi Anak, edisi pertama, Jakarta, Badan Penerbit IDAI, p 350-364
  18. Setiawati L, Iskandar D, Setyoningrum RA (2012). Pneumonia. Pedoman Diagnosis dan Terapi Bagian/SMF Ilmu Kesehatan Anak, Surabaya, Fakultas Kedokteran Universitas Airlangga
  19. Setyoningrum RA and Setiawati L (2011). Profile of community acquired pneumonia in children at Soetomo hospital Surabaya in 2007-2008. Indonesian Journal of Tropical and Infectious Disease 2, 12-14

Most read articles by the same author(s)

1 2 > >>